about
Frequent mechanical stress suppresses proliferation of mesenchymal stem cells from human bone marrow without loss of multipotencyQuantifying adhesion mechanisms and dynamics of human hematopoietic stem and progenitor cellsReplicative senescence of mesenchymal stem cells: a continuous and organized processAging and replicative senescence have related effects on human stem and progenitor cells.Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responses.Specific age-associated DNA methylation changes in human dermal fibroblasts.Trabectedin for metastatic soft tissue sarcoma: a retrospective single center analysis.Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1.The Stromal Activity of Mesenchymal Stromal Cells.Feedback signals in myelodysplastic syndromes: increased self-renewal of the malignant clone suppresses normal hematopoiesis.Mesenchymal stem cells are resistant to carbon ion radiotherapy.The many facets of SDF-1alpha, CXCR4 agonists and antagonists on hematopoietic progenitor cells.Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplaAnalysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement.High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting.Mesenchymal stem cells maintain their defining stem cell characteristics after treatment with cisplatin.Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trialMesenchymal stem cells are sensitive to bleomycin treatment.Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis.Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia.Microcephalin and pericentrin regulate mitotic entry via centrosome-associated Chk1The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin.High pre-transplant serum nitrate levels predict risk of acute steroid-refractory graft-versus-host disease in the absence of statin therapy.Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up.The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.Clonal selection and therapy resistance in acute leukaemias: mathematical modelling explains different proliferation patterns at diagnosis and relapse.miRNAs in multiple myeloma--a survival relevant complex regulator of gene expressionReduced hematopoietic stem cell frequency predicts outcome in acute myeloid leukemia.Human haematopoietic stem cell lineage commitment is a continuous processShear stress regulates adhesion and rolling of CD44+ leukemic and hematopoietic progenitor cells on hyaluronan.Chylous Ascites in a Patient with Inflammatory Myofibroblastic Tumor.Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions.Functional fingerprinting of human mesenchymal stem cells using high-throughput RNAi screening.Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma.Successful unrelated donor stem cell transplantation for advanced myelofibrosis in an adult patient with history of orthotopic liver transplantation.Lenalidomide overcomes the immunosuppression of regulatory CD8+CD28- T-cells.Cisplatin radiosensitizes radioresistant human mesenchymal stem cells.Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trial.Drug-perturbation-based stratification of blood cancer.
P50
Q28834665-05EDC22C-ADC7-496E-904D-1CF1796BB436Q30358968-F48326D7-6E8E-45CC-A87A-F9B023712194Q33336408-92E5C230-47CC-4764-A18C-7D7B3215F603Q33464937-45594640-EC3B-4936-8BA4-8563943A8B68Q33703139-3E258911-7BDA-46D2-A832-6711869D3331Q33828861-45C89AD1-5009-41F5-AF1D-B4AA0A5FB839Q34356540-D7C35610-7F82-4105-9B35-2D93632DF5BDQ34786411-372675AD-5BB3-4AA3-93B6-984EE5CA921BQ34870462-1763B2B2-E2D4-4CB8-BABA-E886C76A2131Q35156907-7F2FD4DD-BDD2-46EC-983D-DCDABE74CC45Q35273369-B19185D7-06BC-4745-813A-6822505CC48EQ35804766-EA4CFA34-AB70-4625-B28D-78C63C047F2CQ35999062-3DB6CEA7-0F03-4BD2-9DBF-CB62B98A9027Q36279071-2577AB3B-B476-4F8E-AA4B-74392C38AE8BQ36287792-0FBE4F86-E276-4FEC-A388-DE158D23291DQ36500869-07797F58-8DD6-4B76-A0E8-3D43E77A7094Q36579055-EB24F8FF-BE3F-4FE3-B2BD-2A03417769B1Q36928779-DE07B880-2100-4ABF-ABF6-A412963B4F37Q37094919-37D0EDB0-AA71-4D29-87F5-AE66D3841F7EQ37212864-E1AFE85E-074B-4AAD-82C4-E5D78EA40F68Q37267614-70D75F94-10D6-46DB-9897-AB304D1C839CQ37389930-6A06DEB7-090A-40A6-8C23-915B90C30E16Q37618927-C1D8D056-4580-47C2-8586-7E90FD362779Q37623386-B7FB0A36-CDE5-4095-8D17-A28CB855B461Q38376616-82655F08-2231-4373-A03B-256168BDEA31Q38492510-A0FA5D50-37A9-48D2-840A-BBC2213D4CFFQ38594523-4B2805E3-44BF-443C-ABC0-350EBF8E3889Q38673891-48D5E2FB-BDD2-4E56-AE60-1DDB1C8A7774Q38760676-C9F0FA29-5A24-4EC3-8EA6-AAE73F38094BQ38893856-6BB6F06A-B197-425E-B15A-7AB60BB3CD49Q39497077-0564EE53-AB35-4311-BC50-469280207BB8Q40400983-4EE5BEC9-5B9B-47EC-BC28-3631DF848140Q40821352-9BB80884-56B9-4A3B-8777-EC655884E46AQ42039513-59B86C2B-97E7-4841-B734-C37977881D4BQ42384494-14D9DA4C-38E3-432D-9C72-095C4AC37341Q43152770-7CFE490C-8C76-4304-94F8-2D46110597C9Q47112048-FB8C4F53-8077-4896-9BF9-E8CB5855D44CQ47120605-576FEC19-4EDB-4D5D-94BA-A26F241A3EF4Q47143616-59004CAF-F209-42EF-B860-3D5E8E7437FDQ47331796-D7335C21-476E-4592-B40D-9C438BB277B6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anthony D Ho
@ast
Anthony D Ho
@en
Anthony D Ho
@es
Anthony D Ho
@nl
type
label
Anthony D Ho
@ast
Anthony D Ho
@en
Anthony D Ho
@es
Anthony D Ho
@nl
prefLabel
Anthony D Ho
@ast
Anthony D Ho
@en
Anthony D Ho
@es
Anthony D Ho
@nl
P108
P106
P31
P496
0000-0002-1656-0833